These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23278369)

  • 41. The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility.
    Liu FX; Alexander GC; Crawford SY; Pickard AS; Hedeker D; Walton SM
    Health Serv Res; 2011 Aug; 46(4):1104-23. PubMed ID: 21609328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Part D coverage gap reform: trends in drug use and expenditures.
    Park J; Look KA
    Am J Manag Care; 2020 Aug; 26(8):349-356. PubMed ID: 32835462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medication adherence, costs, and ER visits of nurse practitioner and primary care physician patients: Evidence from three cohorts of Medicare beneficiaries.
    Muench U; Guo C; Thomas C; Perloff J
    Health Serv Res; 2019 Feb; 54(1):187-197. PubMed ID: 30284237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of national annual variation in total patient out-of-pocket Medicare Part D stand-alone prescription drug plan costs from 2007 to 2008.
    Walberg MP; Patel RA; Amaral MM
    J Med Econ; 2008; 11(4):625-37. PubMed ID: 19450072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.
    Salami JA; Warraich H; Valero-Elizondo J; Spatz ES; Desai NR; Rana JS; Virani SS; Blankstein R; Khera A; Blaha MJ; Blumenthal RS; Lloyd-Jones D; Nasir K
    JAMA Cardiol; 2017 Jan; 2(1):56-65. PubMed ID: 27842171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing Medicare beneficiaries' willingness-to-pay for medication therapy management services.
    Woelfel JA; Carr-Lopez SM; Delos Santos M; Bui A; Patel RA; Walberg MP; Galal SM
    Consult Pharm; 2014 Feb; 29(2):104-9. PubMed ID: 24513420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of manufacturer coupon use in the statin market.
    Daugherty JB; Maciejewski ML; Farley JF
    J Manag Care Pharm; 2013; 19(9):765-72. PubMed ID: 24156645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
    O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY
    Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal medication adherence group-based trajectories of aging adults in the US: A retrospective analysis using monthly proportion of days covered calculations.
    Pontinha VM; Patterson JA; Dixon DL; Carroll NV; Mays D; Barnes A; Farris KB; Holdford DA
    Res Social Adm Pharm; 2024 Mar; 20(3):363-371. PubMed ID: 38176956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data.
    Young JC; Stürmer T; Lund JL; Funk MJ
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):836-43. PubMed ID: 26991151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How does drug treatment for diabetes compare between Medicare Advantage prescription drug plans (MAPDs) and stand-alone prescription drug plans (PDPs)?
    Erten MZ; Stuart B; Davidoff AJ; Shoemaker JS; Bryant-Comstock L; Shenolikar R
    Health Serv Res; 2013 Jun; 48(3):1057-75. PubMed ID: 23205568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of provider mailings on medication adherence by Medicare Part D members.
    Borah BJ; Qiu Y; Shah ND; Gleason PP
    Healthc (Amst); 2016 Sep; 4(3):207-16. PubMed ID: 27637828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antihypertensive and Statin Medication Adherence Among Medicare Beneficiaries.
    Jackson SL; Nair PR; Chang A; Schieb L; Loustalot F; Wall HK; Sperling LS; Ritchey MD
    Am J Prev Med; 2022 Sep; 63(3):313-323. PubMed ID: 35987557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings.
    Song H; Adamson A; Mostaghimi A
    JAMA Dermatol; 2017 Aug; 153(8):755-759. PubMed ID: 28453645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis.
    Karaca-Mandic P; Joyce GF; Goldman DP; Laouri M
    Health Serv Res; 2010 Oct; 45(5 Pt 1):1227-50. PubMed ID: 20831715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in Medication Management After a Diagnosis of Cancer Among Medicare Beneficiaries With Diabetes.
    Stuart BC; Davidoff AJ; Erten MZ
    J Oncol Pract; 2015 Nov; 11(6):429-34. PubMed ID: 26105669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statin Adherence Rates in Patients Utilizing a Patient-Centered Medical Home-Based Pharmacy.
    Slazak EM; Kozakiewicz JT; Winters NS; Smith JR; Monte SV
    J Pharm Pract; 2017 Oct; 30(5):516-520. PubMed ID: 27599748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Out-of-Pocket Cost on Medication Initiation, Adherence, and Persistence among Patients with Type 2 Diabetes: The Diabetes Study of Northern California (DISTANCE).
    Karter AJ; Parker MM; Solomon MD; Lyles CR; Adams AS; Moffet HH; Reed ME
    Health Serv Res; 2018 Apr; 53(2):1227-1247. PubMed ID: 28474736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.
    Fung V; Mangione CM; Huang J; Turk N; Quiter ES; Schmittdiel JA; Hsu J
    Health Serv Res; 2010 Apr; 45(2):355-75. PubMed ID: 20050931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.